baber/WOPTO huggingface dataset:
Patent NZ-190700-A (NZ)
Title: Anti-corrosive toothpaste containing the hydroxide or the carbonate of sodium or potassium
Inventor: TAYLOR C J
IPC: A61K8/19
Filed: 1979-06-11
Abstract: The tendency of gel toothpastes comprising silica thickeners, such as silica aerogel or precipitated silica, and a fluoride source, such as sodium monofluorophosphate or fluoride, to corrode aluminium tubes can be reduced by incorporating at least 0.01 % by weight sodium or potassium hydroxide or carbonate, so that the pH of the toothpaste is at least 8.5.
Patent NZ-204091-A (NZ)
Title: Manufacture of synthetic crystalling zeolite beta with a low aluminium content
Inventor: LA PIERRE R B
IPC: B01J29/00
Filed: 1983-05-03
Abstract: High silica forms of zeolite beta are prepared by aluminum extraction with acid.
Patent NZ-224267-A (NZ)
Title: Poster displaying device: posters displayed in succession
Inventor: GROSSE MAURICE
IPC: G09F11/32
Filed: 1988-04-15
Abstract: Display device comprising shaped guide plates (44) positively guiding the suspension rods (4) of viewing sheets (3) around a roller (8) when each suspension rod (4) is engaged by cradles (11) carried by electrically driven chains (10). A strap (50) which is rendered resilient by the inclusion therein of a spring (53) extends centrally down the rear of the device and prevents the successive suspension rods (4) from becoming detached from the cradles (11) in this region. A gate which includes a stop (55) is provided at the foot of ramps (5) upon which the rods (4) are stacked to ensure that the rods will not become bunched or otherwise entangled on the ramps (5) and that the cradles (11) will positively pick up only one suspension rod (4) at each passage past the gate. A time delay switch (56) is associated with a microswitch (41) and will close to bypass switch (41), after a predetemined interval of time, so that the drive of the device may re-start even if the power supply to the device had previously been switched off with the microswitch (41) in its open circuit position. Each rectangular display sheet (3) preferably comprises two layers which are secured to one another at the edges which coincide with the suspension rods (4) and along one of two longitudinal edges. The other edge is open except for two relatively short portions that are joined together at its opposite ends, whereby webs carrying indicia may be entered between the layers, by appropriate flexing, and will remain trapped therebetween by the short joined together edge portions of the two layers.
Patent NZ-233918-A (NZ)
Title: Fibres comprising aramid and pvp, fabrics therefrom and preparation thereof
Inventor: KIU-SEUNG LEE
IPC: C08L77/10
Filed: 1990-06-01
Abstract: Fibers are disclosed which consist of a combination of para-aramid and poly(vinyl pyrrolidone). The fibers exhibit improved strength and greatly improved dyeability as well as improvements in several other characteristics.
Patent NZ-244976-A (NZ)
Title: Proteins with enzyme activity from s. epidermis, their preparation and their use in biosynthesis of compounds containing dehydroamino and residues and/or thioether bridges
Inventor: ENTIAN KARL-DIETER
IPC: C07K14/00
Filed: 1992-11-02
Abstract: Novel recombinant DNA molecule (I) has a sequence corresp. to one or more DNA sequences contd. in a Bgl II fragment of the 54 Rpb episomal element pTii32 from staphylococcus epidermis and codes for at least one protein having EpiB, EpiC, EpiD, EpiP or EpiQ enzymatic activity; or (I) is capable of hybridising to the BglII fragment and codes for at least one protein with the above enzymatic activities. Also claimed are: the protein EpiB, EpiC, EpiD, EpiP or EpiQ in the absence of impurities with which it is normally associated; a fusion protein compising one of EpiB, C, D, P or Q and an auxiliary protein, a fusion protein in which one of the Epi B, C, D, P or Q is fused to an auxiliary protein such that the junction between the Epi protein and the auxiliary protein can be cleaved by an enzyme; and a method of producing a protein with at least one of the structural features of a lantibiotic. In the novel method comprising inserting a DNA sequence coding for a predetermined aminoacid sequence in a vector plasmid such that it is under the control of a regulator promoter, transforming the resulting plasmid vector into a host and cultivating the host so as to express the DNA and isolating the protein, the improvement comprises also transforming the host by a DNA sequence or sequences comprising functionally operable genes coding for EpiB, C, D, P or Q (or an active variant), the genes being expressed during cultivation of the host so that the resulting protein has at least one of the structural features of a lantibiotic.
Patent NZ-252649-A (NZ)
Title: Removing contaminants from and depolymerisation of (used) polyethylene terephthalate (pet) by transesterification using ethylene glycol at elevated temperature and various purification steps to yield terephthalic acid
Inventor: WEST SIMON MICHAEL
IPC: C08G63/12
Filed: 1993-05-04
Abstract: A process for removing contaminants from PET components by depolymerising poly ethylene terephthalate ("PET") comprising transesterifying material containing PET by reacting ethanediol having a temperature at or about the boiling point of ethanediol with the material for a predetermined period of time to form a solution containing soluble short chain PET polymers and/or bis (hydroxy ethyl) terephthalate ester ("BHT"); recovering short chain PET polymers and/or BHT and ethanediol; and hydrolysing the recovered short chain PET polymers and/or BHT at elevated pressure and temperature for a predetermined period of time to form an ethanediol solution and crystals of terephthalic acid.
Patent NZ-258345-A (NZ)
Title: Peptides (opioid) capable of selectively binding to cell receptors
Inventor: KIM SUN HYUK
IPC: C07K5/065
Filed: 1993-11-04
Abstract: Opioid peptides including those of the formula   <IMAGE>   in which A1 is the identifying group of an amino acid selected from 3,4-dihydroxyphenylalanine, 3,4-dimethoxyphenylalanine, azatyrosine, and 2,6-dimethyltyrosine; A2 is the identifying group of an amino acid selected from D-Ala and D-Arg; A3 is H, or the identifying group of an amino acid selected from of 3,4-dihydroxyphenylalanine and 3,4-dimethoxyphenylalanine, A4 is H, cyclohexylmethyl, the identifying group of an amino acid selected from 3,4-dihydroxyphenylalanine, 3,4-dimethoxyphenylalanine, Phe, and substituted Phe with its benzene ring substituted by halogen, NO2, OH, or CH3; A5 is the identifying group of a D- or L-amino acid selected from Leu, Nle, Lys, Met and Met(O), or is deleted together with R4-CH attached thereto; each R1 and R2 is -H, -C(NH2)=NH, or C1-12 alkyl; R3 is   <IMAGE>   R4 is   <IMAGE>   and R5 is -(CH2)n+1OH,   <IMAGE>   wherein m is 0-6, n is 0-6, and X is H, C1-12 alkyl, C6-12 aryl, C7-18 aralkyl, C7-18 alkaryl, C7-18 alkayl, C6-17 pyridylalkyl, or C6-17 alkylpyridyl; provided that when one of R1 and R2 is -C(NH2)=NH, the other must be H; or a pharmaceutically acceptable salt thereof.
Patent NZ-272092-A (NZ)
Title: Use of rapamycin to prevent vascular disease
Inventor: MORRIS RANDALL ELLIS
IPC: A61K31/395
Filed: 1995-05-09
Abstract: This invention provides a method of preventing hyperproliferative vascular disease in a mammal by administering an antiproliferative effective amount of rapamycin alone or in combination with mycophenolic acid.
Patent NZ-295172-A (NZ)
Title: Medicament-inhaler with sensors & means for calculating amount administered
Inventor: DENYER JONATHAN STANLEY HAROLD
IPC: A61M11/00
Filed: 1995-10-27
Abstract: PCT No. PCT/EP95/04254 Sec. 371 Date Jul. 14, 1997 Sec. 102(e) Date Jul. 14, 1997 PCT Filed Oct. 27, 1995 PCT Pub. No. WO96/13294 PCT Pub. Date May 9, 1996An apparatus for administering a fluid medicament to a patient in a gas for inhalation and for calculating the dosage administered to the patient comprising a holding member (1) for temporarily holding the medicament and gas prior to inhalation, means for introducing a quantity of the medicament into the holding chamber (1), a sensor (4) for detecting the introduction of the medicament into the holding chamber (1), detector means for detecting the rate of flow of gas inhaled by a patient from the holding chamber (1) and calculation means (25, 27, 29, 30, 31) operably connected to the sensor (4) and to the detector means for calculating the amount of medicament received by a patient. The calculating means (25, 27, 29, 30, 31) makes its calculation on the basis of the quantity of medicament released into the holding chamber (1), the volume of the holding chamber (1), the time elapsed from the detection of the introduction of the medicament, and the detected rate of flow of gas inhaled from the holding chamber (1). The calculation being made by assessing the concentration of the medicament in the holding chamber (1) on a time basis during reduction of the said concentration within the holding chamber (1), and be determining the volume of the gas received by the patient during inhalation, and the time elapsed from the detected introduction of medicament to the inhalation by the patient.
Patent NZ-334450-A (NZ)
Title: Apparatus and methods for active biological sample preparation
Inventor: SHELDON EDWARD L
IPC: B01J19/00
Filed: 1997-07-31
Abstract: An apparatus for active biological sample preparation adapted to separate desired materials from undesired materials comprises a first sample chamber 12 adapted to receive a buffer solution and a second sample chamber 14 adapted to receive a buffer solution.  A spacer region 16 is disposed between first sample chamber 12 and second sample chamber 14.  Spacer region 16 provides a trap having differential effect on the desired materials versus undesired materials.  A first electrode 26 is adapted for electrical contact with the buffer solution when located within first sample chamber 12.  A second electrode 28 is adapted for electrical contact with the buffer solution when in second sample chamber 14.  A protective layer is between first sample chamber and first electrode 26, thereby forming a first electrode chamber 18.  The protective layer is a membrane 22.
Patent NZ-334505-A (NZ)
Title: Light- and bright-coloured antifouling paints comprising 2-trihalogenomethyl-3-halogeno-4-cyano pyrrole derivatives that are suitable as barnaclecides
Inventor: KRAMER JOHANNES PETRUS
IPC: C09D201/00
Filed: 1997-09-19
Abstract: 2-Trihalogenomethyl-3-halogeno-4-cyano pyrrole derivatives substituted in position 5 and optionally in position 1 are used as barnaclecide in antifouling paints, which can therefore be formulated as light- or bright-coloured, particularly as bright white. The substituent in position 5 is selected from the group consisting of C1-8 alkyl, C1-8 monohalogenoalkyl, C5-6 cycloalkyl, C5-6 monohalogenocycloalkyl, benzyl, phenyl, mono- and di-halogeno-benzyl or -phenyl, mono- and di-C1-4 alkyl benzyl or phenyl, and monohalogeno mono-C1-4-alkyl benzyl or phenyl. The optional substituent in position 1 is selected from the group consisting of C1-4 alkyl and C1-4 alkoxy C1-4 alkyl. Antifouling paints may contain 0.5 to 9.9 wt.% of barnaclecide, based on the total weight of the dry mass of the composition, preferably 1 to 6 wt.%, most preferably 1.5 to 4 wt.%.
Patent NZ-335256-A (NZ)
Title: An air distributor or collector
Inventor: PALMER EDWARD G
IPC: F24F13/068
Filed: 1997-09-17
Abstract: An airflow apparatus is disclosed for controlled distribution or collection of low velocity air. To collect air, a fan (40) draws air (51) from the proximal end of an elongated tube (20) disposed in an air-environment (50). Airflow through the tube's distal end is controlled by a tube terminator (30). The tube terminator may be an air impermeable cap completely preventing distal-end airflow. Tube (20) receives air all along its length through openings (21) in its wall. The wall is more air permeable per unit surface area of said wall, at its distal end, than at its proximal end. Wall permeability progressively increases from the proximal end to the distal end. A preferred tube type has a substantially constant rate of air ingestion at all points along the wall. Reversal of the airflow direction in the tube converts the air collector into an air distributor.
Patent NZ-335854-A (NZ)
Title: Toothbrush with angled tufts and/or different types of tufts with differing cross-sectional areas
Inventor: BEALS DONNA
IPC: A46B5/02
Filed: 1998-11-06
Abstract: A toothbrush (10) having a handle (12) and a plurality of tufts of bristles (26) secured to the head (14). In one embodiment one of the tufts is secured to the head (14) at a location such that no other tuft is secured to the head at a location that is more distal from the handle (12) than the location where the one tuft is secured to the head (14). The one tuft is angled by about 81 degrees or less relative to an imaginary line which is tangent to a co-planar with a surface of the head through which the one tuft secured to the head (14). The one tuft is tilted away from the handle (12) towards a direction along which the head (14) extends from the handle (12). Various other embodiments are disclosed with the common features being at least two longitudinal rows of tufts tilting in opposite longitudinal directions.
Patent NZ-505372-A (NZ)
Title: Tokenless vending machine
Inventor: PONS ROBERT M
IPC: G06Q20/26
Filed: 2000-06-23
Abstract: Disclosed is a method of and an apparatus for "tokenless" vending, and "tokenless" shopping to enable an account holder to buy goods and services without having to be in possession of cash, cards, or any other physical token of value or identity. To make a purchase, the purchaser simply inputs his account number and password on a keypad at a vending machine or other point of sale. The point of sale equipment transmits the account code and password to a central server. The server determines whether the said at least one code input by the purchaser agrees with the at least one identifying code associated with an active account. The vendor system confirms, either at the server or at the point of sale, that the price of the desired goods or services does not exceed the available credit on the purchaser's account. If all is in order, the goods or services are provided to the purchaser at the point of sale, and the server reduces the available credit on the account accordingly.
Patent NZ-508579-A (NZ)
Title: Aspartyl dipeptide ester derivatives and salts that can be used as sweeteners
Inventor: AMINO YUSUKE
IPC: A23L1/275
Filed: 1999-06-07
Abstract: Aspartyl dipeptide ester derivatives and salts of formula (1), that may be suitable for use as sweetener in food or edible products where: R1, R2, R3, R4 and R5, are H, OH, alkoxy, alkyl or a hydroxyalkyloxy group or R1 and R2, or R2 and R3 together form a methylenedioxy group (OCH2O) wherein R4, R5, and R1 or R3 which does not form the methylenedioxy group, independently from each other, each represents any substituents as mentioned above; R6 is a hydrogen atom, a benzyl (CH2C6H5), a p-hydroxybenzyl (CH2C6H4-p-OH), a cyclohexylmethyl (CH2C6H11), a phenyl (C6H5), a cyclohexyl (C6H11), a phenylethyl (CH2CH2C6H5) or a cyclohexylethyl group (CH2CH2C6H11); R7 is a hydrogen atom, a methyl (CH3), an ethyl (CH2CH3) or an isopropyl group (CH(CH3)2); R8 is methyl, ethyl, isopropyl, n-propyl (CH2CH2CH3) or a t-butyl group (C(CH3)3); provided the derivatives in which R6 represents a benzyl group and R7 represents a hydrogen atom at the same time, and the derivatives in which R6 represents a p-hydroxybenzyl group and R7 represents a hydrogen atom at the same time are excluded.
Patent NZ-510645-A (NZ)
Title: Gripper for strapping machine, consisting of floating portion and stationary portion, with interengaging teeth and grooves
Inventor: BELL LEMUEL J
IPC: B65B13/06
Filed: 2001-03-20
Abstract: In order to allow for variations in strap width and thickness a gripper assembly is provided with a fixed gripper element 26 cooperating with a floating gripper element 24.  The elements 26, 24 have cooperating central teeth and channels.
Patent NZ-513810-A (NZ)
Title: Compositions and methods for improved delivery of hydrophobic therapeutic agents
Inventor: PATEL MANESH V
IPC: A61K9/48
Filed: 2000-01-05
Abstract: The present invention relates to triglyceride-free pharmaceutical compositions for delivery of hydrophobic therapeutic agents. Compositions of the present invention include a hydrophobic therapeutic agent and a carrier, where the carrier is formed from a combination of a hydrophilic surfactant and a hydrophobic surfactant. Upon dilution with an aqueous solvent, the composition forms a clear, aqueous dispersion of the surfactants containing the therapeutic agent. The invention also provides methods of treatment with hydrophobic therapeutic agents using these compositions.
Patent NZ-515419-A (NZ)
Title: Method and device for simulating detonating projectiles with sensors and transmitters
Inventor: LAZECKI RENE
IPC: F41G3/26
Filed: 2001-11-12
Abstract: Detonating projectiles are fired into a target area  by a  weapon, the time between firing and detonation being  one second  or less. By setting the target location at the  same distance  as  e.g. the edge (1) of a building  (3),  however laterally  displaced  with  respect  to  that  edge,  it  is possible  to  obtain an effect also in an area invisible  to the  bearer  of the weapon. For simulating this weapon,  for example in house-to-house fighting, it is proposed to  affix devices (5) comprising a sensor (22) and a transmitter  (27) to  obstacles. When the weapon is fired, a simulation device provided  on  the weapon transmits a firing  signal  to  the sensor  (22),  the  latter activating the transmitter  (27). Similarly  to the real effect of the weapon, the transmitter (27)  emits  an impact signal in the impact area (7),  which also includes the mentioned area, which is invisible to  the bearer   of  the  weapon.  On  account  of  the  independent operation  of  the transceiver unit (5), it is  possible  to simulate  the  effect  of this weapon substantially  without delay as compared to reality.
Patent NZ-515741-A (NZ)
Title: Portable mosquito net having a frame with elongate members connected to one another at their ends
Inventor: WHITTINGTON DALE
IPC: A47C29/00
Filed: 2000-05-03
Abstract: A portable mosquito net apparatus 10 is formed of a frame 20, adapted to be sandwiched between a bed mattress and a mattress support surface and is held in place by the weight of the mattress.  The frame 20 mounts a mosquito net support to which a mosquito net 12 is attached in a position over the mattress.  The frame 20 has three elongate rigid members 42a, 42b, 42c connected to one another at their respective ends.  The frame has first 22 and second portions 24.  The first portion is sandwiched between the mattress and the mattress support surface and the second portion extends beyond the mattress. The mosquito net is draped down about the edges of the mattress to form an enclosed space.  The frame, mosquito net support, and mosquito net can be easily disassembled for storage or transport in a small luggage bag.
Patent NZ-518875-A (NZ)
Title: Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
Inventor: TOURAUD FRANCK
IPC: A61K9/52
Filed: 2000-10-11
Abstract: A suspension of particles as carriers (PV) for active principles (PA) is described. The vector particles (PV) are based on polyamino acids (PAA). They have a mean hydrodynamic diameter (Dh) ranging between 30 and 120 nm and have an insulin load factor (Ta) ranging between 5 and 25% of associated insulin volume relative to the polyamino acid volume forming the carrier principles. The polyamino acids are double-block polymers comprising hydrophilic (AAI) and hydrophobic (AAO) monomers. Also described is a solid powder substance from which are derived the carrier particles and the preparation of the solid powder substance and suspension of carrier particles. The preparation consists in copolymerising N-carboxy anhydrides of hydrophobic monomers and precursors of hydrophilic monomers, in the presence of N-methyl pyrrolidone and methanol. The precursors of the hydrophilic monomers are then transformed into hydrophilic monomers by acid hydrolysis. Optionally, the copolymer is neutralised, subjected to dialysis, concentrated and the water is eliminated. Thus a solid powder substance or suspended carrier particles are produced. Active principles (such as insulin or vaccines) are associated with the carrier particles for preparing special pharmaceutical products.
Patent NZ-525793-A (NZ)
Title: Humanized anti-LT-beta-R antibodies
Inventor: GARBER ELLEN
IPC: C07K19/00
Filed: 2001-10-12
Abstract: Disclosed is a humanized anti-lymphotoxin-beta receptor (LT-beta-R) antibody whose light chain complementary determining regions are defined by amino acid residues 24-34, 50-56 and 89-97 of SEQ ID NO:1, and whose heavy chain complementary determining regions are defined by amino acid residues 31-35, 50-66 and 99 -109 of SEQ ID NO: 2 and wherein the antibody comprises at least one of the following residues in its light chain; K3, W41, I46, Q69 and Y71; or at least one of the following residues in its heavy chain: F37, T40, A49, M89 and V93 (Kabat numbering convention).
Patent NZ-535233-A (NZ)
Title: Volume measurement of liquids
Inventor: GOULDSWORTHY BETH
IPC: G01F19/00
Filed: 2003-02-13
Abstract: A bedpan comprises a body (1) formed to provide a first chamber (2) for receiving liquid and a second chamber provided with a scale (11) for measuring the volume of the liquid received in the first chamber. Liquid received in the first chamber (2) can be transferred to the second chamber by tilting the bedpan, and this second chamber is arranged to create a deeper body of liquid so that relatively small variations in the volume of liquid result in relatively large variations in the level of liquid in the second chamber which can be measured more accurately.
Patent NZ-539807-A (NZ)
Title: Pharmaceutical composition comprising an immunoregulator peptide from the beta-loop 2 region of beta-HGC capable of regulating Th1 and/or Th2 cell activity for treating chronic inflammation
Inventor: KAHN NISAR A
Filed: 2001-03-29
Abstract: Provided is a use of an immunoregulator peptide obtained or derived from the beta-loop 2 region of beta-HCG capable of regulating Th1 and/or Th2 cell activity for the production of a pharmaceutical composition for the treatment of a chronic inflammatory immune-mediated disorder. Also described are a pharmaceutical compositions and a method for treating an immune-mediated disorder. Immune-mediated disorders as include chronic inflammatory disease, such as diabetes type I or II, rheumatic disease, Sjögrens syndrome, multiple sclerosis transplantation-related immune responses such as graft-versus-host-disease and post-transfusion cytothrombopenia.